ZTOX CATEGORY

MARKSANS PHARMA

3 weeks ago

Marksans Pharma Q4 FY 26 Earnings Call Transcript Now on NSE

Marksans Pharma has published the transcript of its Q4 FY 26 earnings conference call with analysts on NSE, covering the company's audited financial results for the quarter.

Continue Reading
3 weeks ago

Marksans Pharma Q4 FY26 Analyst Call Transcript Published on NSE

Marksans Pharma has made its Q4 FY26 investor call transcript available via NSE filing. The document covers the audited financial results presentation to analysts and institutional investors.

Continue Reading
3 weeks ago

Marksans Pharma (MARKSANS): Analysts/Institutional Investor Meet/Con. Call Updates

Analysts/Institutional Investor Meet/Con. Call Updates Marksans Pharma Limited has informed the Exchange about Transcript of Investors/Analyst meet on Q4 FY 26 Audited Financial Results Marksans Pharma Limited has informed the Exchange about Transcript of Investors/Analyst meet on Q4 FY 26 Audited Financial Results Marksans Pharma Limited has informed the Exchange about Transcript of Investors/Analyst meet on Q4 FY 26 Audited Financial Results Marksans Pharma Limited has informed the Exchang

Continue Reading
3 weeks ago

Marksans Pharma Urges Shareholders for KYC Updates Ahead of IEPF Transfer

Marksans Pharma has initiated a shareholder engagement campaign urging investors to complete KYC updations and claim pending dividends before these are transferred to the Investor Education and Protection Fund (IEPF).

Continue Reading
3 weeks ago

Marksans Pharma (MARKSANS): Company Update

Company Update Campaign for KYC and other related updations and shareholders engagement to prevent transfer of unclaimed dividend to IEPF Campaign for KYC and other related updations and shareholders engagement to prevent transfer of unclaimed dividend to IEPF Campaign for KYC and other related updations and shareholders engagement to prevent transfer of unclaimed dividend to IEPF

Continue Reading
3 weeks ago

Marksans Pharma (MARKSANS): Press Release

Press Release Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 01, 2026, titled "Marksans Pharma to Acquire 100% of Netherlands-based QliniQ B.V., Strengthening Presence in European Markets". Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 01, 2026, titled "Marksans Pharma to Acquire 100% of Netherlands-based QliniQ B.V., Strengthening Presence in European Markets". Marksans Pharma Limited has informed the Exchange reg

Continue Reading
1 year ago

MARKSANS PHARMA Q3 FY25 Results

MARKSANS PHARMA Q3 FY25 Results

Continue Reading
1 year ago

MARKSANS PHARMA Q2 FY25 Results

MARKSANS PHARMA Q2 FY25 Results

Continue Reading
2 years ago

MARKSANS PHARMA Q3 FY24 Results

MARKSANS PHARMA Q3 FY24 Results

Continue Reading
Plans built for every investor
TRUSTED BY INVESTORS

Track Indian stocks with ZTOX AI

NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.

RK
VJ
SM

"ZTOX alerts helped me catch a multi-bagger stock last quarter. The insider deals notifications are absolutely game-changing for retail investors."

Rahul K., Active Trader
MOST POPULAR
Basic Plan
For active market participants
₹89/mo
Includes:
Track 20 Companies
Insider deals alert
High volume alerts
Start Free
Advanced Plan
For serious investors & traders
₹119/mo
Includes:
Track 50 Companies
All Basic plan features
Block & Preferential Deals
Start Free

No credit card required. Connect WhatsApp or Telegram in minutes.

Secure connection. Your data is always protected.